| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000020996 |
| Receipt No. | R000023931 |
| Official scientific title of the study | Long-term quality-of-life evaluation in patients after Esophagectomy by EORTC QLQ-OES and C-30 |
| Date of disclosure of the study information | 2016/02/19 |
| Last modified on | 2018/01/31 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Long-term quality-of-life evaluation
in patients after Esophagectomy by EORTC QLQ-OES and C-30 |
|
| Title of the study (Brief title) | The QOL evaluation in patients after esophagectomy | |
| Region |
|
|
| Condition | ||
| Condition | esophageal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To estimate the quality-of-life in patients after Esophagectomy by EORTC QLQ-OES and C-30
|
| Basic objectives2 | Others |
| Basic objectives -Others | To clarify the effect of surgical approach, reconstruction route, and other clinico-pathological factors on QOL. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | aw scores of each QOL questionnaire (EORTC QLQ-OES and C-30)and VAS |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)patients underwent subtotal esophagectomy for esophageal cancer
2) Provided written informed consent |
|||
| Key exclusion criteria | 1) Considered inadequate for inclusion in this trial by the physician
2) Patients without consent for enrollment |
|||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Masahiko Koike |
| Organization | Nagoya University Graduate School of Medicine |
| Division name | Department of Gastroenterological Surgery (Surgery II) |
| Address | 65 Tsurumai-cho, Showa-ku, Nagoya, Japan |
| TEL | 052-744-2250 |
| dockoike@med.nagoya-u.ac.jp | |
| Public contact | |
| Name of contact person | Yukiko Niwa |
| Organization | Nagoya University Hospital |
| Division name | Quality and Patient Safety |
| Address | 65 Tsurumai-cho, Showa-ku, Nagoya, Japan |
| TEL | 052-744-2250 |
| Homepage URL | |
| yukiko-niwa@med.nagoya-u.ac.jp | |
| Sponsor | |
| Institute | Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Prospective single-institutional study, In patients fulfilling the criteria, QOL survey will carry out using EORTC-QLQ-C30/OES18. Survey is scheduled as follows; EORTC-QLQ-C30/OES18: preoperatively, on discharge, on postoperative 6,12,24-month. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023931 |